Bill Ackman supports Valeant Pharma (VRX) CEO Pearson - CNBC
(Updated - November 5, 2015 2:23 PM EST)
Bill Ackman supports Valeant Pharma (NYSE: VRX) CEO Mike Pearson, according to a letter seen by CNBC.
In a letter to Mr. Person, Ackman said, "In light of recent press reports, I though it would be helpful for me to communicate my thoughts on your leadership of Valeant. We share the board's confidence in you and your leadership."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bessent: Think Druckenmiller Lost Money Day He Sent Editorial
- Lunai Bioworks expands naked short selling lawsuit to add six broker-dealers
- FTC and 22 states sue Amazon over alleged secret ad auction surcharges
Create E-mail Alert Related Categories
Hedge Funds, Management Changes, Short Sales, Trader TalkRelated Entities
William AckmanSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share